1,3-dihydro-2H-indol-2one derivatives, process for preparing...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C544S106000, C544S141000, C544S144000, C544S358000, C544S373000, C548S466000, C514S231200, C514S233500, C514S414000

Reexamination Certificate

active

07129240

ABSTRACT:
The invention relates to compounds of formula:as well as the possible salts thereof with mineral or organic acids, and the solvates and/or hydrates thereof, which have affinity for and selectivity towards the V1breceptors or towards both the V1band V1areceptors of arginine-vasopressin.The invention also relates to the process for preparing them, to the intermediate compounds of formula (II) that are useful for preparing them, to pharmaceutical compositions containing them and to their use for the preparation of medicinal products.

REFERENCES:
patent: 5338755 (1994-08-01), Wagnon et al.
patent: 5594023 (1997-01-01), Wagnon et al.
patent: 5773612 (1998-06-01), Wagnon et al.
patent: 6730695 (2004-05-01), Roux et al.
patent: WO 95/18105 (1995-07-01), None

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

1,3-dihydro-2H-indol-2one derivatives, process for preparing... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 1,3-dihydro-2H-indol-2one derivatives, process for preparing..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1,3-dihydro-2H-indol-2one derivatives, process for preparing... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3690560

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.